Zou H - Search Results

1

Protein disulfide isomerases are promising targets for predicting the survival and tumor progression in glioma patients.

Peng Z, Chen Y, Cao H, Zou H, Wan X, Zeng W, Liu Y, Hu J, Zhang N, Xia Z, Liu Z, Cheng Q. Peng Z, et al. Among authors: zou h. Aging (Albany NY). 2020 Feb 5;12(3):2347-2372. doi: 10.18632/aging.102748. Epub 2020 Feb 5. Aging (Albany NY). 2020. PMID: 32023222 Free PMC article.

2

P4HB and PDIA3 are associated with tumor progression and therapeutic outcome of diffuse gliomas.

Zou H, Wen C, Peng Z, Shao YΥ, Hu L, Li S, Li C, Zhou HH. Zou H, et al. Oncol Rep. 2018 Feb;39(2):501-510. doi: 10.3892/or.2017.6134. Epub 2017 Dec 4. Oncol Rep. 2018. PMID: 29207176 Free PMC article.

3

The Basic Characteristics of the Pentraxin Family and Their Functions in Tumor Progression.

Wang Z, Wang X, Zou H, Dai Z, Feng S, Zhang M, Xiao G, Liu Z, Cheng Q. Wang Z, et al. Among authors: zou h. Front Immunol. 2020 Aug 18;11:1757. doi: 10.3389/fimmu.2020.01757. eCollection 2020. Front Immunol. 2020. PMID: 33013829 Free PMC article. Review.

4

The tRNA-Cys-GCA Derived tsRNAs Suppress Tumor Progression of Gliomas via Regulating VAV2.

Ren J, Wu X, Shang FF, Qi Y, Tang Z, Wen C, Cao W, Cheng Q, Tan L, Chen H, Zhou HH, Zou H. Ren J, et al. Among authors: zou h. Dis Markers. 2022 Nov 15;2022:8708312. doi: 10.1155/2022/8708312. eCollection 2022. Dis Markers. 2022. PMID: 36426134 Free PMC article.

5

lncRNAs PVT1 and HAR1A are prognosis biomarkers and indicate therapy outcome for diffuse glioma patients.

Zou H, Wu LX, Yang Y, Li S, Mei Y, Liu YB, Zhang L, Cheng Y, Zhou HH. Zou H, et al. Oncotarget. 2017 Aug 12;8(45):78767-78780. doi: 10.18632/oncotarget.20226. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108264 Free PMC article.

6

REST, not REST4, is a risk factor associated with radiotherapy plus chemotherapy efficacy in glioma.

Li C, Zou H, Wang Z, Tang X, Fan X, Zhang K, Liu J, Li Z. Li C, et al. Among authors: zou h. Drug Des Devel Ther. 2018 May 22;12:1363-1371. doi: 10.2147/DDDT.S161602. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 29861627 Free PMC article.

7

Pseudogenes of annexin A2, novel prognosis biomarkers for diffuse gliomas.

Li S, Zou H, Shao YY, Mei Y, Cheng Y, Hu DL, Tan ZR, Zhou HH. Li S, et al. Among authors: zou h. Oncotarget. 2017 Oct 31;8(63):106962-106975. doi: 10.18632/oncotarget.22197. eCollection 2017 Dec 5. Oncotarget. 2017. PMID: 29291003 Free PMC article.

8

SREBP1 as a potential biomarker predicts levothyroxine efficacy of differentiated thyroid cancer.

Li C, Peng X, Lv J, Zou H, Liu J, Zhang K, Li Z. Li C, et al. Among authors: zou h. Biomed Pharmacother. 2020 Mar;123:109791. doi: 10.1016/j.biopha.2019.109791. Epub 2019 Dec 27. Biomed Pharmacother. 2020. PMID: 31887541 Free article.

9

Correction: Shao et al. AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells. Int. J. Mol. Sci. 2017, 18, 350.

Shao YY, Zhang TL, Wu LX, Zou HC, Li S, Huang J, Zhou HH. Shao YY, et al. Int J Mol Sci. 2021 Nov 24;22(23):12670. doi: 10.3390/ijms222312670. Int J Mol Sci. 2021. PMID: 34884979 Free PMC article.

10

AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells.

Shao YY, Zhang TL, Wu LX, Zou HC, Li S, Huang J, Zhou HH. Shao YY, et al. Int J Mol Sci. 2017 Feb 10;18(2):350. doi: 10.3390/ijms18020350. Int J Mol Sci. 2017. PMID: 28208619 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

5,674 results

Search Page

Filters